Log In Register
Cart
Advanced Search
x
Select a CAS section from the 5 main topical divisions below:
Subscriber access provided by UNIV OF NORTH TEXAS SYSTEM

An N,N-Bis(benzimidazolylpicolinoyl)piperazine (BT-11): A Novel Lanthionine Synthetase C-Like 2-Based Therapeutic for Inflammatory Bowel Disease

Adria Carbo, Richard D. Gandour, Raquel Hontecillas, Noah Philipson, Aykut Uren, and Josep Bassaganya-Riera*

Pharmacokinetics and Metabolism of Selective Oxoeicosanoid (OXE) Receptor Antagonists and Their Effects on 5-Oxo-6,8,11,14-eicosatetraenoic Acid (5-Oxo-ETE)-Induced Granulocyte Activation in Monkeys

Chantal Cossette, Shishir Chourey, Qiuji Ye, Chintam Nagendra Reddy, Vivek Gore, Sylvie Gravel, Irina Slobodchikova, Dajana Vuckovic, Joshua Rokach, and William S. Powell*

Insights of a Lead Optimization Study and Biological Evaluation of Novel 4-Hydroxytamoxifen Analogs as Estrogen-Related Receptor γ (ERRγ) Inverse Agonists

Jina Kim, Seo Yeon Woo, Chun Young Im, Eun Kyung Yoo, Seungmi Lee, Hyo-Ji Kim, Hee-Jong Hwang, Joong-heui Cho, Won Seok Lee, Heeseok Yoon, Shinae Kim, Oh-bin Kwon, Hayoung Hwang, Kyung-Hee Kim, Jae-Han Jeon, Thoudam Debraj Singh, Sang Wook Kim, Sung Yeoun Hwang, Hueng-Sik Choi, In-Kyu Lee, Seong Heon Kim, Yong Hyun Jeon*, Jungwook Chin*, and Sung Jin Cho*

Antibacterial and Antibiofilm Activity of Cationic Small Molecules with Spatial Positioning of Hydrophobicity: An in Vitro and in Vivo Evaluation

Jiaul Hoque, Mohini M. Konai, Shanola S. Sequeira, Sandip Samaddar, and Jayanta Haldar*

Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations

Alessio Nocentini, Marta Ferraroni, Fabrizio Carta, Mariangela Ceruso, Paola Gratteri, Cecilia Lanzi, Emanuela Masini, and Claudiu T. Supuran*

Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity

Flavia Varano*, Daniela Catarzi, Fabrizio Vincenzi, Marco Betti, Matteo Falsini, Annalisa Ravani, Pier Andrea Borea, Vittoria Colotta, and Katia Varani

    Articles ASAP (As Soon As Publishable)

    ASAP articles are edited and published online ahead of issue. See all ASAP articles.

    N-Heterocyclic (4-Phenylpiperazin-1-yl)methanones Derived from Phenoxazine and Phenothiazine as Highly Potent Inhibitors of Tubulin Polymerization

    Helge PrinzAnn-Kathrin Ridder, Kirsten Vogel, Konrad J. Böhm, Igor Ivanov, Jahan B. Ghasemi, Elham AghaeeKlaus Müller
    Publication Date (Web): January 3, 2017 (Article)
    DOI: 10.1021/acs.jmedchem.6b01591
    Figure

    Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)

    Georgette M. CastanedoNicole Blaquiere, Maureen Beresini, Brandon Bravo, Hans Brightbill, Jacob Chen, Hai-Feng Cui, Charles Eigenbrot, Christine Everett, Jianwen Feng, Robert Godemann, Emily Gogol, Sarah Hymowitz, Adam Johnson, Nobuhiko Kayagaki, Pawan Bir Kohli, Kathleen Knüppel, Joachim Kraemer, Susan Krüger, Pui Loke, Paul McEwan, Christian Montalbetti, David A. Roberts, Myron Smith, Stefan Steinbacher, Swathi Sujatha-Bhaskar, Ryan Takahashi, Xiaolu Wang, Lawren C. Wu, Yamin Zhang, Steven T. Staben
    Publication Date (Web): December 22, 2016 (Article)
    DOI: 10.1021/acs.jmedchem.6b01363
    Figure

    The Essential Medicinal Chemistry of Curcumin

    Kathryn M. NelsonJayme L. Dahlin, Jonathan Bisson, James Graham, Guido F. Pauli, Michael A. Walters
    Publication Date (Web): January 11, 2017 (Perspective)
    DOI: 10.1021/acs.jmedchem.6b00975
    Figure

    Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach

    Hiroshi NaraAkira Kaieda, Kenjiro Sato, Takako Naito, Hideyuki Mototani, Hideyuki Oki, Yoshio Yamamoto, Haruhiko Kuno, Takashi Santou, Naoyuki Kanzaki, Jun Terauchi, Osamu Uchikawa, Masakuni Kori
    Publication Date (Web): December 14, 2016 (Article)
    DOI: 10.1021/acs.jmedchem.6b01007
    Figure

    Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe

    Philip G. HumphreysPaul Bamborough, Chun-wa Chung, Peter D. Craggs, Laurie Gordon, Paola Grandi, Thomas G. Hayhow, Jameed Hussain, Katherine L. Jones, Matthew Lindon, Anne-Marie Michon, Jessica F. Renaux, Colin J. Suckling, David F. Tough, Rab K. Prinjha
    Publication Date (Web): December 21, 2016 (Article)
    DOI: 10.1021/acs.jmedchem.6b01566
    Figure
    See More

    Just Accepted Manuscripts

    Just Accepted manuscripts are peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. See all Just Accepted Manuscripts.

    α-Ketothioamide derivatives: a promising tool to interrogate the phosphoglycerate dehydrogenase (PHGDH)

    Séverine Ravez, Cyril Corbet, Quentin Spillier, Alice Dutu, Anita D Robin, Edouard Mullarky, Lewis Clayton Cantley, Olivier Feron, and Raphaël Frédérick
    Publication Date (Web): January 13, 2017 (Brief Article)
    DOI: 10.1021/acs.jmedchem.6b01166
    Figure

    Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker.

    James R. Corte, Tianan Fang, Honey Osuna, Donald J. P. Pinto, Karen A Rossi, Joseph E Myers, Steven Sheriff, Zhen Lou, Joanna J Zheng, Timothy W. Harper, Jeffrery M. Bozarth, Yiming Wu, Joseph M Luettgen, Dietmar A Seiffert, Carl P. Decicco, Ruth R. Wexler, and Mimi L Quan
    Publication Date (Web): January 13, 2017 (Article)
    DOI: 10.1021/acs.jmedchem.6b01460
    Figure

    Design, Synthesis and Biological Evaluation of Novel, Non-Brain Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis

    Malliga R Iyer, Resat Cinar, Alexis Katz, Michael Gao, Katalin Erdelyi, Tony Jourdan, Nathan J Coffey, Pal Pacher, and George Kunos
    Publication Date (Web): January 13, 2017 (Article)
    DOI: 10.1021/acs.jmedchem.6b01504
    Figure

    Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-targeting Pyruvate Dehydrogenase Kinase Inhibitors

    Shih-Chia Tso, Mingling Lou, Cheng-Yang Wu, Wen-Jun Gui, Jacinta L. Chuang, Lorraine K. Morlock, Noelle S Williams, Richard Max Wynn, Xiangbing Qi, and David T. Chuang
    Publication Date (Web): January 13, 2017 (Article)
    DOI: 10.1021/acs.jmedchem.6b01540
    Figure

    Optimization of 2-anilino 4-amino substituted quinazolines into potent antimalarial agents with oral in vivo activity

    Paul R Gilson, Cyrus Tan, Kate E. Jarman, Kym N. Lowes, Joan M. Curtis, William Nguyen, Adrian E. Di Rago, Hayley E. Bullen, Boris Prinz, Sandra Duffy, Jonathan B. Baell, Craig A Hutton, Helene Jousset Sabroux, Brendan S. Crabb, Vicky M. Avery, Alan F. Cowman, and Brad E. Sleebs
    Publication Date (Web): January 12, 2017 (Article)
    DOI: 10.1021/acs.jmedchem.6b01673
    Figure
    See More

    Current Issue

    The latest published issue of Journal of Medicinal Chemistry. See all articles.

    Journal of Medicinal Chemistry, Technological Advances: Highlights 2015–2016

    Stevan W. Djuric and Nicholas A. Meanwell
    Publication Date (Web): November 8, 2016 (Editorial)
    DOI: 10.1021/acs.jmedchem.6b01600
    Figure

    Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors

    Wei Tuo, Natascha Leleu-Chavain, John Spencer, Supojjanee Sansook, Régis Millet, and Philippe Chavatte
    Publication Date (Web): October 21, 2016 (Perspective)
    DOI: 10.1021/acs.jmedchem.6b00538
    Figure

    Class II Phosphoinositide 3-Kinases as Novel Drug Targets

    Marco Falasca, Justin R. Hamilton, Maria Selvadurai, Krithika Sundaram, Aleksandra Adamska, and Philip E. Thompson
    Publication Date (Web): September 20, 2016 (Perspective)
    DOI: 10.1021/acs.jmedchem.6b00963
    Figure

    Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain

    Bryan H. Norman and Jeff S. McDermott
    Publication Date (Web): October 25, 2016 (Perspective)
    DOI: 10.1021/acs.jmedchem.6b00964
    Figure

    Fragment-to-Lead Medicinal Chemistry Publications in 2015

    Christopher N. Johnson, Daniel A. Erlanson, Christopher W. Murray, and David C. Rees
    Publication Date (Web): October 14, 2016 (Perspective)
    DOI: 10.1021/acs.jmedchem.6b01123
    Figure
    See More

    Most Read Articles

    Most Read articles are refreshed daily and are based on full text downloads (PDF and HTML) from the previous 30 days and previous 12 months. Below is a Top 5 excerpt from the previous 30 days.

    Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis

    Ben Gold, Robert Smith, Quyen Nguyen, Julia Roberts, Yan Ling, Landys Lopez Quezada, Selin Somersan, Thulasi Warrier, David Little, Maneesh Pingle, David Zhang, Elaine Ballinger, Matthew Zimmerman, Véronique Dartois, Paul Hanson, Lester A. Mitscher, Patrick Porubsky, Steven Rogers, Frank J. Schoenen, Carl Nathan, and Jeffrey Aubé
    Publication Date (Web): May 4, 2016 (Featured Article)
    DOI: 10.1021/acs.jmedchem.5b01833
    Figure

    A Versatile Method to Determine the Cellular Bioavailability of Small-Molecule Inhibitors

    Kevin B. Teuscher, Min Zhang, and Haitao Ji
    Publication Date (Web): December 9, 2016 (Article)
    DOI: 10.1021/acs.jmedchem.6b00923
    Figure

    Combining Molecular Scaffolds from FDA Approved Drugs: Application to Drug Discovery

    Richard D. TaylorMalcolm MacCoss, Alastair D. G. Lawson
    Publication Date (Web): December 9, 2016 (Perspective)
    DOI: 10.1021/acs.jmedchem.6b01367
    Figure

    Recent Advances in Scaffold Hopping

    Ye Hu, Dagmar Stumpfe, and Jürgen Bajorath
    Publication Date (Web): December 21, 2016 (Perspective)
    DOI: 10.1021/acs.jmedchem.6b01437
    Figure

    Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease

    Jack D. Scott, Sarah W. Li, Andrew P. J. Brunskill, Xia Chen, Kathleen Cox, Jared N. Cumming, Mark Forman, Eric J. Gilbert, Robert A. Hodgson, Lynn A. Hyde, Qin Jiang, Ulrich Iserloh, Irina Kazakevich, Reshma Kuvelkar, Hong Mei, John Meredith, Jeffrey Misiaszek, Peter Orth, Lana M. Rossiter, Meagan Slater, Julie Stone, Corey O. Strickland, Johannes H. Voigt, Ganfeng Wang, Hongwu Wang, Yusheng Wu, William J. Greenlee, Eric M. Parker, Matthew E. Kennedy, and Andrew W. Stamford
    Publication Date (Web): November 18, 2016 (Drug Annotation)
    DOI: 10.1021/acs.jmedchem.6b00307
    Figure
    See More

    Journal of Medicinal Chemistry Special Issues highlight work being conducted in emerging and high-interest topical areas of medicinal chemistry.

    New Issue

    Computational Methods for Medicinal Chemistry


    Recent Issues

    View all Journal of Medicinal Chemistry Special Issues

    ACS Editors' Choice

    View the most recent ACS Editors' Choice articles from Journal of Medicinal Chemistry.

    See all Journal of Medicinal Chemistry ACS Editors' Choice articles.

    View one new peer-reviewed research article from any ACS journal, selected daily, and made open access based on recommendations by ACS journal scientific editors from around the world. As a service to our global community of researchers, the articles listed below will remain open for all to access and read.

    See all ACS Editors’ Choice articles from ACS Journals.

    Publication Cover
    Editor-in-Chief:

    Gunda I. Georg

    and

    Shaomeng Wang

    Total Citations
    Impact Factor
    Articles Published
    2014 Journal Citation Reports® by Thomson Reuters, 2015
    ADVERTISEMENT
    ADVERTISEMENT

    Featured Content

    Perspectives are designed to provide an enlightened appraisal of a field of research in which experts review the "state of the art" for a given topic.

    View the latest Perspectives

    Drug Annotations are reports of drug candidates in phase I, II, and III clinical trials, as well as new drugs in the market.

    View Editor-selected, previously published research on topics of current scientific interest.

    See more Journal of Medicinal Chemistry Virtual Issues

    View the Virtual Issue Collection.

    C&EN Latest News

    Biological SCENE

    Organic SCENE